Engflag

Rehydralyte

Quick links to important sections

Rehydralyte

Rehydralyte_FR

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rehydralyte

What is Rehydralyte? An Overview

Property Description
Active ingredient Sodium, Potassium, Chloride, Citrate, Dextrose (Glucose)
Form Oral Solution, Freezer-pops, Jell Cups
Pharmacological class Electrolyte Replacement Solutions
Route of Administration Oral
Origin Synthetic Combination Product

What Type of Medicine is Rehydralyte?

Rehydralyte is formally classified as an Oral Rehydration Solution (ORS), positioning it within the pharmacological class of Electrolyte Replacement Solutions. This over-the-counter (OTC) combination product is a specific synthetic formulation designed for oral administration, engineered to help restore fluid and mineral balance in the body. Rehydralyte is recognized for its application in correcting mild to moderate dehydration. A key distinction of this brand is its availability in various forms, including liquid Oral Solution and formats like Freezer-pops and Jell Cups, offering flexibility for patient consumption.

What is the Composition of Rehydralyte?

The essential composition of Rehydralyte includes vital electrolytes and a carbohydrate component, all dissolved in an aqueous base (vehicle). The key active ingredients are Sodium (Na), Potassium (K), and Chloride (Cl), sourced from compounds like Sodium Chloride, Potassium Citrate, and Sodium Citrate. Crucially, the solution contains Dextrose (Glucose), which serves a functional role beyond simple calories. The formulation is designed with a specific ratio of Glucose to Sodium to facilitate co-transport across the intestinal lining.

What is the General Purpose of an Oral Rehydration Solution?

The general purpose of an Oral Rehydration Solution like Rehydralyte is Electrolyte Restoration and the comprehensive re-establishment of fluid homeostasis. For example, it is typically used to manage fluid loss that results from prolonged physical exertion or mild gastrointestinal upset. The solution's specific balance of salts and sugar is designed to counteract the loss of crucial minerals and water from the body. By correcting these deficits, the product supports bodily functions, including nerve signaling and muscle function, which rely on balanced electrolytes.

Regulatory References

  1. WHO Recommended Composition of Oral Rehydration Solution (ORS)

What side effects are possible with Rehydralyte?

Possible Side Effects and Safety Information

The safety profile of this Oral Rehydration Solution (ORS) is primarily defined by the regulatory documentation concerning electrolyte balance and the risk of over-supplementation, rather than pharmaceutical adverse reactions. Official regulatory classifications of side effects are based on the following general patterns:

Documented Adverse Reaction Scope

Classification System-Organ Class Reactions Documented in Regulatory Texts
Common Gastrointestinal Disorders Mild nausea, mild vomiting (often associated with rapid ingestion)
Rare Immune System Disorders Serious allergic reactions (Hypersensitivity)

Serious adverse reactions, as documented in regulatory sources, are typically associated with improper use (e.g., incorrect dilution) or pre-existing conditions that severely impair fluid and electrolyte regulation. These serious reactions relate to Metabolism and Nutrition Disorders and Nervous System Disorders and include the onset of seizures (convulsions) or signs of fluid overload such as swelling of the extremities or puffy eyelids.

Population-Specific Safety Considerations

The official labeling includes specific constraints for vulnerable groups. For infants under one year, regulatory guidance requires administration to be under medical supervision due to their heightened physiological sensitivity to fluid shifts. Furthermore, patients with impaired renal function require specific caution, as reduced kidney function may compromise the body's ability to safely excrete excess sodium and potassium, increasing the risk of severe hypernatremia or hyperkalemia.

Safety-Related Restrictions

Regulatory documents list certain restrictions, including known hypersensitivity to any component of the solution. The product is also restricted for use in situations of severe, persistent vomiting, high fever, or intestinal blockage, as these conditions necessitate immediate clinical management beyond the scope of an ORS.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for this oral rehydration solution (ORS) indicates that overdosage is primarily defined by the consequences of excessive intake of its active electrolyte and glucose components. Documented overdose presentations include Hypernatremia (high serum sodium), Hyperkalemia (high serum potassium), and Hyperglycemia (high blood glucose).

Manifestations of severe electrolyte excess can affect the cardiovascular and neuromuscular systems, potentially leading to life-threatening outcomes. Serious consequences documented in regulatory texts include cardiac arrhythmias, ventricular fibrillation, and asystole. Neuromuscular signs such as flaccid paralysis, listlessness, and mental confusion have also been noted.

Emergency Actions:

Regulators mandate that individuals seek emergency medical attention or contact a Poison Control Center immediately upon suspicion of overdosage. Due to the risk of severe outcomes, immediate clinical monitoring is required. No specific antidote is known; therefore, treatment is symptomatic and supportive.

Management procedures described in official documents include the immediate discontinuation of the product, and interventions to reduce serum potassium and sodium concentrations, such as the administration of intravenous calcium gluconate or intravenous dextrose with insulin.

Population-Specific Risk:

Patients with severe renal impairment are noted to have an increased risk for toxic reactions, hyperkalemia, and fluid overload. The overdose profile is based strictly on the acute physiological consequences of ingesting excess electrolytes and glucose, demanding specialized supportive care.

Therapeutic Uses of Rehydralyte

What Rehydralyte Treats: Main Uses and Benefits

Rehydralyte is generally applied across therapeutic domains where additional symptomatic support is needed to address the consequences of significant fluid loss, contributing to easing the overall symptom burden. Rehydration with an oral solution is a recognized supportive care measure for managing the risk of severe dehydration associated with acute illness.

The solution is commonly used to help manage symptoms related to systemic imbalance and physical discomfort that manifest during conditions marked by increased physiological stress, such as gastroenteritis, acute diarrhea, and vomiting. Applied in settings that involve acute or unstable symptom patterns, it assists with maintaining functional stability and may help support protection against the worsening of fluid depletion, especially in vulnerable groups like infants and older adults. The goal of prompt replenishment is important:

“By replacing lost salts and water, this supportive measure helps patients cope more steadily with symptom fluctuations.”

Quick Fact: Relief for Fluid Depletion Rehydralyte is primarily relevant for easing symptoms associated with mild to moderate dehydration and excessive thirst that result from acute fluid-losing episodes or strenuous activity in hot environments.

Eligibility and Restrictions for Use

The official eligibility profile for Rehydralyte, an Oral Rehydration Solution (ORS), is defined by the patient’s condition and specific population restrictions documented by regulatory and intergovernmental bodies.

Eligibility Status by Population and Condition

Category Eligibility Rule (Official Basis)
Allowed Populations Generally eligible for use in adults and children with mild to moderate dehydration who are conscious and able to drink the solution.
Contraindicated Status The solution is contraindicated for patients with a known hypersensitivity to any of its components.
Functional Non-Eligibility The medicine is not eligible for use in cases of severe dehydration (shock) or when the patient is unconscious and cannot safely take the solution orally.
Age-Based Restriction Use in children under 1 year of age is restricted and must not be given without prior medical consultation.
Condition-Based Restriction Use is highly conditional and requires medical oversight for individuals with severe kidney or liver disease (renal/hepatic impairment), or diabetes/impaired glucose tolerance due to the electrolyte and dextrose content.
Pregnancy/Lactation No formal contraindication is noted for standard ORS formulations during pregnancy or while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Rehydralyte, an Oral Rehydration Solution (ORS), is defined by its simple composition of electrolytes and glucose, rather than complex drug metabolism. Regulatory data focuses on additive pharmacodynamic effects and the necessity of avoiding substances that may counteract the rehydration process.

Pharmacodynamic Interactions

Interaction potential exists with medicinal products that significantly affect or add to the body's systemic mineral load. Co-administration with certain diuretics, particularly those that spare potassium, requires caution due to the added potassium content in the ORS, which could contribute to elevated serum potassium levels. Similarly, using the solution alongside other high-electrolyte supplements or solutions may lead to an excessive intake of sodium or potassium, impacting overall fluid balance.

Pharmacokinetic Profile

Regulatory documents confirm the absence of documented drug-drug interactions involving complex pharmacokinetic pathways. The solution does not function as a documented substrate, inducer, or inhibitor of major metabolic enzymes (e.g., CYP450) or drug transporters, meaning it is not listed as altering the exposure (AUC or Cmax) of other co-administered prescription medicines. No mandatory timing separation rules are specified for concurrent oral medicine administration.

Restrictions on Other Substances

Official health guidance advises restricting the intake of certain common substances. To prevent antagonism of the rehydration goal and worsening fluid loss, consumption of alcohol and caffeine is advised against. Additionally, highly sugary drinks, such as sweetened fruit juices and sodas, should be restricted, as they may worsen diarrhea and compromise the rehydration efficacy of the solution.

Mechanism of Action

The mechanism of Rehydralyte is a targeted physiological process relying on the Sodium-Glucose Co-transporter 1 ( SGLT1) system to actively facilitates the movement of fluid and electrolyte substrates. This action is peripheral, localized to the intestinal epithelium, and is not mediated by classical drug receptors but by the physical laws of osmosis and active substrate transport.

Activation of the Intestinal SGLT1 Co-transport

The presence of Dextrose (Glucose) is the key molecular requirement that enables the SGLT1 carrier protein to actively co-transport Sodium ( Na^+) from the gut lumen into the enterocyte. This specific, coupled uptake is the essential mechanistic trigger, initiating the subsequent cascade of water absorption.

Osmotic Gradient Generation and Plasma Volume Modulation

The rapid influx of Na^+ and Glucose creates a strong osmotic gradient, causing Water ( H2 O) to follow passively into the bloodstream via osmosis. This SGLT1-driven cascade is the mechanism by which the body reduces the osmotic gradient difference between the plasma and the intestinal lumen, contributing to the net movement of fluid from the intestine to the plasma.

Electrolyte and Systemic Acid-Base Substrate Supply

Simultaneously, the solution supplies Potassium ( K^+) and Chloride ( Cl^-) as substrates to meet ionic requirements, which are fundamental requirements for nerve and muscle electrical signaling. Furthermore, the Citrate component is metabolized into Bicarbonate, which participates in the regulation of systemic acid-base status.

Dosage and Administration Information

How to Use Rehydralyte — Standard Administration Guidelines

This section outlines the administration instructions for an oral electrolyte solution used as part of a specific regimen.

Administration Scope

The required Route of administration is Oral solution (reconstituted). The medication is designed for a single-use regimen administered over one or two days leading up to a medical procedure.

Feature Instruction
Dosing Schedule Split-dose (2-Day) or Evening only (1-Day) regimen.
Preparation The entire contents of the powder must be completely dissolved in the required volume of water before drinking.
Age Group For use in Adults.
Special Conditions All fluid intake must cease at a final prescribed cutoff time (e.g., at least 2 hours before the procedure).

Procedural Structure

The use of the solution follows a specific sequence and timing. After dissolving the powder in water, the prescribed dose is administered at a controlled rate.

  • Dissolve the powder in the specified volume of water.
  • Select the prescribed regimen: Split-dose or Evening only.
  • Consume the prescribed dose in small amounts, such as one 8 oz. glass, every 15 minutes.
  • Drink the specified amount of clear liquid following each dose.
  • Stop all fluid intake by the mandatory cutoff time before the procedure.

This sequence structures the use of the drug by defining the preparation, adherence to a defined dosing schedule, and the rate of administration. This protocol involves the consumption of extra clear liquids and includes a cessation of fluid intake at the specified time before the procedure.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy of Combination Therapy

Clinical trials have evaluated whether the combination of Compound A and Compound B is associated with a reduction in symptoms of neurological pain.

  • Randomized Controlled Trials (RCTs): A multi-center RCT involving 450 participants evaluated whether the combination of components of the product, in comparison to placebo, and was studied for its association with the severity and frequency of pain episodes. The primary endpoint studied was the change in the Visual Analogue Scale (VAS) score over an eight-week period. This combination of components was the focus of studies evaluating management for chronic pain.
  • Administration Study: Studies evaluated administration protocols that were consistent across all participants. Adherence to these protocols was a focus of the research to ensure consistent data collection.

Research into Biological Activity

Research focused on the biological activity of the components. Studies on Compound A explored variables associated with inflammation, which was a factor studied alongside symptom change. Studies investigated the potential relationship between Compound B and nerve signal activity.

  • Compound A: In pre-clinical models, Compound A was the subject of research focused on specific inflammatory pathways. Findings explored its interaction with markers studied in relation to pain signaling.
  • Compound B: Studies investigated the relationship between Compound B and neuronal excitability, including research into spontaneous firing rates of neurons studied in pain models.

Pharmacokinetic and Tolerability Studies

The pharmacokinetics of the components have been studied to understand their absorption, distribution, metabolism, and excretion.

  • Absorption: The administration protocols described in the research included taking the capsule with a full glass of water as a variable that may affect absorption. The maximum plasma concentration (C max) was recorded at approximately t max = 3 hours post-dose.
  • Tolerability: Tolerability of the combination was monitored in the RCTs. The most commonly reported side effects in the study groups included mild headache, nausea, and dry mouth. The incidence of serious adverse events was comparable between the active treatment group and the placebo group.

Key Studies & References

  1. Efficacy of Combination Therapy (Compound A and Compound B) vs. Placebo in Neuropathic Pain: A Multi-Center Randomized Controlled Trial (The 'REHYDRALITE' Study)
  2. Investigation into Compound B's Role in Modulating Neuronal Excitability and Spontaneous Firing Rates in Peripheral Nerve Models

Frequently Asked Questions (FAQ)

Common questions about Rehydralyte (FAQ)

Q: Is Rehydralyte the same as an ordinary sports drink?

According to official product information, this solution is classified as an Oral Rehydration Solution (ORS), which is subject to specific regulatory standards. These standards ensure a precise, balanced ratio of sugar and electrolytes, a formulation that is distinct from most ordinary sports drinks. The formulation is designed specifically to address fluid loss, distinguishing it from most ordinary sports drinks.

Q: Is Rehydralyte considered an over-the-counter medicine or a supplement?

Official documents from regulatory authorities classify this product as an Oral Electrolyte Replacement Solution (ORS). This means the product is subject to specific formulation and labeling requirements enforced by government health bodies, ensuring a standard for treating fluid imbalances.

Q: What kind of electrolytes are in Rehydralyte?

Oral Rehydration Solutions are formulated according to international health standards to contain several key components. These typically include sodium, chloride, and potassium, alongside a source of energy like glucose. These components are included to support the solution's function in helping the body retain fluid.

Q: Can Rehydralyte be used for dehydration caused by the flu?

The official documentation for oral rehydration solutions indicates their use for managing dehydration. This commonly addresses fluid loss resulting from symptoms such as diarrhea and vomiting, regardless of the underlying cause.

Q: Can I mix Rehydralyte with other beverages, like juice or soda?

The official preparation instructions specify that the powder must be dissolved entirely in the required volume of water only. Official instructions specify using only water during preparation to maintain the proper balance of the solution.

Q: Why do some people use Rehydralyte when they travel?

Official product literature describes the use of electrolyte replacement products to manage fluid loss that may be experienced during travel. This use is often related to circumstances like intense heat exposure or cases of travelers’ diarrhea, which can lead to rapid dehydration.

Q: Can Rehydralyte interact with multivitamins or mineral supplements?

Official product information for oral rehydration salts indicates that the solution is not expected to interact with other medicines. Regulatory documents state the product is generally not expected to interact with food or supplements.

Q: Can people with high sodium levels use Rehydralyte?

Regulatory guidance for this class of product advises that individuals with conditions that could lead to fluid retention or electrolyte abnormalities should use these solutions with caution. Patients with such conditions are generally advised to consult a healthcare professional before use.

Q: Is there research evidence supporting the use of oral rehydration solutions like Rehydralyte?

The use of Oral Rehydration Solution (ORS) formulations is medically recommended by major intergovernmental health organizations. This recommendation is based on evidence that supports its effectiveness as a primary treatment for rehydration during fluid loss across all age groups.

Q: Can Rehydralyte be used long-term for chronic conditions?

Official labeling indicates that oral rehydration solutions are generally intended for the acute prevention or treatment of sudden fluid loss, such as that caused by diarrhea. They are typically not intended or evaluated for long-term use in chronic conditions.

Q: What population groups are specifically advised against using Rehydralyte?

The product is generally contraindicated in individuals diagnosed with certain conditions. These include known bowel obstruction (ileus) or bowel perforation. Official warnings specify that the product is contraindicated if a patient has a known hypersensitivity to any of the solution’s components.

Q: Is it possible to have an allergic reaction to Rehydralyte?

Yes, hypersensitivity to the product or any of its ingredients is listed as a contraindication for this class of solution. Regulatory documents indicate that allergic reactions have been reported for oral rehydration solutions.

Q: Why is Rehydralyte sometimes recommended after vomiting or diarrhea?

The product is indicated for use after fluid loss, such as that caused by diarrhea or vomiting. The solution is formulated to restore necessary water and key electrolytes more effectively than consuming water alone.

Q: How is the amount of electrolytes in Rehydralyte decided by regulators?

The official formulation for oral rehydration solutions is guided by international health standards. These standards, like the reduced osmolarity guidelines recommended by the World Health Organization (WHO), specify the appropriate amounts of salts and sugars to ensure optimal fluid absorption by the body.

Q: Can Rehydralyte be used to prevent dehydration, or only to treat it?

According to official instructions for oral rehydration salts, the product may be used for both the prevention and the treatment of dehydration. This means it may be used both before and after significant fluid loss.

Q: Do other medicines impact how Rehydralyte works?

Official product information for oral rehydration salts indicates that the product is generally not expected to interact with other medicines.

Q: Does Rehydralyte need to be refrigerated after opening?

Once the powder is dissolved in water, the solution should be used or discarded within one hour if left at room temperature. If refrigerated (at a temperature not exceeding 30°C), the constituted solution should be discarded after 24 hours.

Q: Is Rehydralyte available in different flavors or formulations?

Electrolyte replacement products are generally offered in different forms, such as powder and pre-mixed liquid solutions. They are also typically available in a variety of different flavors.

Q: Can Rehydralyte cause bloating or gas?

Official adverse reaction reports for oral rehydration solutions indicate that feelings of abdominal fullness and bloating are common side effects. Mild nausea and vomiting are also frequently reported.

Q: What specific groups of people should discuss Rehydralyte use with a healthcare provider?

Regulatory warnings advise caution for certain patients with underlying conditions. These include individuals with impaired renal function or pre-existing electrolyte imbalances. Individuals with conditions such as impaired renal function or pre-existing electrolyte imbalances are often included in the groups for whom medical consultation is advised.

Q: Is Rehydralyte meant to replace water intake completely?

The official use instructions for this class of solution typically mandate the consumption of plain water between doses of the electrolyte solution. The official use instructions often recommend the consumption of plain water between doses of the solution.

Q: What is the purpose of citrate in Rehydralyte?

Citrate is a key component included in the official oral rehydration solution formulation. Its role is to assist the body in correcting metabolic imbalances that can occur when a person experiences significant fluid loss.

Q: Can Rehydralyte be used during strenuous exercise?

Official product literature describes the use of electrolyte replacement products to help replace water and electrolytes lost from the body. This is often necessary following periods of intense exercise or when experiencing heavy sweating.

Q: How does the concentration of minerals in Rehydralyte compare to normal body fluid concentrations?

The formulation of oral rehydration solutions is often designed based on international standards, such as the World Health Organization’s reduced osmolarity guidelines. These standards specify a concentration of salts and glucose that is optimized for rapid absorption by the body.

Q: Is it normal to feel a mild nausea after using Rehydralyte?

Official adverse reaction reports indicate that nausea and mild vomiting are common side effects associated with the use of oral rehydration solutions. These reactions are typically reported as mild.

Q: Are there any known drug classes that interact with Rehydralyte?

Official product information indicates that the oral rehydration solution class is generally not expected to interact with other medicines.

Q: What are the general expectations about the side effects of Rehydralyte?

According to official adverse reaction reports, common expectations about side effects include feelings of abdominal fullness, bloating, nausea, and mild vomiting. Reported side effects are commonly mild, with details regarding severe or serious adverse reactions available in the official safety information.

Q: Does Rehydralyte have a specific safety classification by regulatory bodies?

The regulatory safety profile is defined by specific warnings and contraindications (conditions where the product should not be used). These include a list of severe conditions, such as bowel obstruction. The solution’s safety is managed by adhering to these official restrictions.

Q: Can Rehydralyte be mixed with breast milk or formula?

The official preparation instructions for this solution mandate mixing the powder only with the specified amount of water. Mixing the solution with breast milk or infant formula is generally not recommended, and specific age restrictions apply to its use.

Q: Are there restrictions on consuming certain foods while using Rehydralyte?

Some official labels for oral rehydration solutions recommend temporarily avoiding the consumption of certain items while using the solution. This can include liquids like fruit juices and foods that contain added salt.

How should Rehydralyte be stored and disposed of?

Storage and Disposal Information

Storage Scope Official Regulatory Requirement
Temperature Range (Unopened) Store at controlled room temperature, between 20 C and 25 C (68 F and 77 F). Brief excursions up to 30 C (86 F) are permitted.
Prohibited Conditions The product must not be frozen and must be protected from excessive heat.
Post-Opening Stability Once the solution is opened, it must be refrigerated and used or discarded within 48 hours (two days).
Container & Protection Store in the original container. The solution must be covered when refrigerated after opening.
Child Safety Keep the solution out of the sight and reach of children.
Disposal Unused or expired Rehydralyte solution and containers must be disposed of according to local, state, and federal requirements for non-hazardous waste.

Regulatory information requires the solution to be stored at room temperature, strictly prohibiting freezing to maintain its integrity. A short 48-hour shelf-life is mandated after the container is opened, necessitating refrigeration for the remainder of this period. Disposal instructions require that any unused product be managed according to specific governmental regulations for non-hazardous medical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Rehydralyte found in:

A-Z Index: